|
TORONTO, ONTARIO--(Marketwired - June 15, 2015) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") announces that its previously issued $500,000 principal amount convertible debenture due June 12, 2015, has been re-paid in full. The Corporation has arranged an interim shareholder demand loan to facilitate the repayment, which it expects to repay with the proceeds of a private placement that it has arranged. Under the private placement, the Corporation expects to raise gross proceeds of $500,000 through the issuance of units at a price of $0.17 per unit. Each unit will be comprised of one common share of the Corporation and one-half of one common share purchase warrant, with each whole warrant being exercisable into one common share at a price of $0.20 for a period of two years. |
